Background. Integrase strand transfer inhibitors (INSTIs) are crucial for the treatment of human immunodeficiency virus (HIV) type 2 infection, due to limited available therapeutic options. Recently, ...
LOS ANGELES (Reuters) - Merck & Co. Inc.'s experimental HIV drug in a new class called integrase inhibitors can control the virus in nearly 80 percent of previously treated patients, when combined ...
A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based therapies, particularly useful for patients with integrase inhibitor ...
The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the neurochemical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback